Protein replacement therapies for rare diseases: a breeze for regulatory approval?, Sci. Transl. Med, vol.5, pp.178-110, 2013. ,
Enzyme replacement therapy: efficacy and limitations, Ital. J. Pediatr, vol.44, p.120, 2018. ,
In vivo genome editing restores haemostasis in a mouse model of haemophilia, Nature, vol.475, pp.217-221, 2011. ,
Functional correction of large factor VIII gene chromosomal inversions in hemophilia A patient-derived iPSCs using CRISPR-Cas9, Cell Stem Cell, vol.17, pp.213-220, 2015. ,
Promoterless gene targeting without nucleases ameliorates haemophilia B in mice, Nature, vol.517, pp.360-364, 2015. ,
In vivo genome editing of the albumin locus as a platform for protein replacement therapy, Blood, vol.126, pp.1777-1784, 2015. ,
Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseases, JCI Insight, vol.5, p.128863, 2019. ,
Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors, Hum. Gene Ther, vol.21, pp.704-712, 2010. ,
Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors, J. Clin. Invest, vol.119, pp.1688-1695, 2009. ,
Identification of preexisting adaptive immunity to Cas9 proteins in humans, Nat. Med, vol.25, pp.249-254, 2019. ,
Hepatitis B virus infection enhances susceptibility toward adeno-associated viral vector transduction in vitro and in vivo, Hepatology, vol.59, pp.2110-2120, 2014. ,
AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers, Gene Ther, vol.19, pp.411-417, 2012. ,
Erythropoiesis: development and differentiation. Cold Spring Harb, Perspect. Med, vol.3, p.11601, 2013. ,
Clinical manifestations of alpha-thalassemia, Cold Spring Harb. Perspect. Med, vol.3, p.11742, 2013. ,
Stem cell-derived erythroid cells mediate long-term systemic protein delivery, Nat. Biotechnol, vol.24, pp.1017-1021, 2006. ,
Reprogramming erythroid cells for lysosomal enzyme production leads to visceral and CNS cross-correction in mice with Hurler syndrome, Proc. Natl. Acad. Sci. USA, vol.106, 2009. ,
The beta-globin locus control region in combination with the EF1alpha short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activity, Mol. Ther, vol.20, pp.1400-1409, 2012. ,
Establishment of immortalized human erythroid progenitor cell lines able to produce enucleated red blood cells, PLoS ONE, vol.8, p.59890, 2013. ,
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors, Nat. Biotechnol, vol.33, pp.1256-1263, 2015. ,
Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR, Genome Biol, vol.17, p.148, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01346049
COSMID: a web-based tool for identifying and validating CRISPR/Cas off-target sites, Mol. Ther. Nucleic Acids, vol.3, p.214, 2014. ,
Easy quantitative assessment of genome editing by sequence trace decomposition, Nucleic Acids Res, vol.42, p.168, 2014. ,
Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors, Nat. Biotechnol, vol.33, pp.175-178, 2015. ,
An unbiased genome-wide analysis of zinc-finger nuclease specificity, Nat. Biotechnol, vol.29, pp.816-823, 2011. ,
Preclinical development of a lentiviral vector for gene therapy of X-linked severe combined immunodeficiency, Mol. Ther. Methods Clin. Dev, vol.9, pp.257-269, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02178311
X-linked thrombophilia with a mutant factor IX (factor IX Padua), N. Engl. J. Med, vol.361, pp.1671-1675, 2009. ,
In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia, Proc. Natl. Acad. Sci. USA 105, pp.10547-10552, 2008. ,
Editing the sickle cell disease mutation in human hematopoietic stem cells: comparison of endonucleases and homologous donor templates, Mol. Ther, vol.27, pp.1389-1406, 2019. ,
Precise gene editing preserves hematopoietic stem cell function following transient p53-mediated DNA damage response, Cell Stem Cell, vol.24, p.558, 2019. ,
The cell biology of lysosomal storage disorders, Nat. Rev. Mol. Cell Biol, vol.5, pp.554-565, 2004. ,
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice, Blood, vol.106, pp.1565-1573, 2005. ,
Macrophages prevent human red blood cell reconstitution in immunodeficient mice, Blood, vol.118, pp.5938-5946, 2011. ,
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells, Nat. Med, vol.24, pp.1216-1224, 2018. ,
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity, Cell, vol.154, pp.1380-1389, 2013. ,
CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations, Nat. Commun, vol.10, p.1136, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02395971
Sorting of lysosomal proteins, Biochim. Biophys. Acta, vol.1793, pp.605-614, 2009. ,
Comparison of human cord blood engraftment between immunocompromised mouse strains, Blood, vol.116, pp.193-200, 2010. ,
Manipulating the mouse genome to engineer precise functional syntenic replacements with human sequence, Cell, vol.128, pp.197-209, 2007. ,
Limitations of enzyme replacement therapy: current and future, J. Inherit. Metab. Dis, vol.29, pp.442-447, 2006. ,
Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment, Nat. Biotechnol, vol.26, pp.901-908, 2008. ,
Complexity of immune responses to AAV transgene products -Example of factor IX, Cell Immunol, vol.342, p.103658, 2019. ,
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy, Science, vol.326, pp.818-823, 2009. ,
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy, Science, vol.341, p.1233158, 2013. ,
Platelet gene therapy by lentiviral gene delivery to hematopoietic stem cells restores hemostasis and induces humoral immune tolerance in FIX(null) mice, Mol. Ther, vol.22, pp.169-177, 2014. ,
Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A mice, Thromb. Haemost, vol.105, pp.676-687, 2011. ,
Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia A mice transplanted with genetically manipulated human cord blood stem cells, Blood, vol.123, pp.395-403, 2014. ,
Erythroid-specific human factor IX delivery from in vivo selected hematopoietic stem cells following nonmyeloablative conditioning in hemophilia B mice, Mol. Ther, vol.16, pp.1745-1752, 2008. ,
Engineering a lysosomal enzyme with a derivative of receptorbinding domain of apoE enables delivery across the blood-brain barrier, Proc. Natl. Acad. Sci. USA, vol.110, pp.2999-3004, 2013. ,
Memory of tolerance and induction of regulatory T cells by erythrocytetargeted antigens, Sci. Rep, vol.5, p.15907, 2015. ,
Engineering antigens for in situ erythrocyte binding induces T-cell deletion, Proc. Natl. Acad. Sci. USA, vol.110, pp.60-68, 2013. ,
Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease, Proc. Natl. Acad. Sci. USA, vol.114, pp.3157-3162, 2017. ,
Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin, Nat. Commun, vol.8, p.423, 2017. ,
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ss-thalassemia, Nat. Med, vol.25, pp.234-241, 2019. ,
Targeting the niche: depleting haemopoietic stem cells with targeted therapy, Bone Marrow Transpl, vol.54, pp.961-968, 2019. ,
New agents in HSC mobilization, Int J. Hematol, vol.105, pp.141-152, 2017. ,
Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery, Nat. Biotechnol, vol.25, pp.1298-1306, 2007. ,
On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver, Nat. Med, vol.22, pp.945-951, 2016. ,
High-level protein production in erythroid cells derived from in vivo transduced hematopoietic stem cells, Blood Adv, vol.3, pp.2883-2894, 2019. ,
Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery, Chem. Soc. Rev, vol.45, pp.4690-4707, 2016. ,
Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain, Dev. Med. Child Neurol, vol.60, pp.579-586, 2018. ,
Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector, Nucleic Acids Res, vol.42, p.147, 2014. ,
Improved methods of AAV-mediated gene targeting for human cell lines using ribosome-skipping 2A peptide, Nucleic Acids Res, vol.44, p.54, 2016. ,
High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice, PLoS ONE, vol.6, p.18556, 2011. ,
Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences, Nat. Genet, vol.25, pp.217-222, 2000. ,
Optimization of CRISPR/Cas9 delivery to human hematopoietic stem and progenitor cells for therapeutic genomic rearrangements, Mol. Ther, vol.27, pp.137-150, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02880803
Production, purification and characterization of adeno-associated vectors, Curr. Gene Ther, vol.10, pp.423-436, 2010. ,
Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR, J. Virol. Methods, vol.106, pp.81-88, 2002. ,
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis, Nature, vol.527, pp.192-197, 2015. ,
Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins, Sci. Rep, vol.5, p.14410, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01271745
Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing, J. Hematol. Oncol, vol.10, p.119, 2017. ,
Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors, Blood Adv, vol.1, pp.2019-2031, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02377508
Neural stem cells for disease modeling of Wolman disease and evaluation of therapeutics, Orphanet. J. Rare Dis, vol.12, p.120, 2017. ,
A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2, Clin. Chim. Acta, vol.413, pp.1207-1210, 2012. ,
NIH Image to ImageJ: 25 years of image analysis, Nat. Methods, vol.9, pp.671-675, 2012. ,